ISABS: Personalized Medicine Conference with Nobel Prize Laureates Participation to be held in Dubrovnik, Croatia

Food and Healthcare Press Releases Thursday March 16, 2017 08:37
ZAGREB, Croatia and WASHINGTON--16 Mar--PRNewswire/InfoQuest

International Society for Applied Biological Sciences (ISABS), Mayo Clinic and St. Catherine Hospital in partnership with Philips are organizing "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" ( http://www.isabs.hr ), to be held in Dubrovnik, June 19th - June 24th, 2017. ISABS Conference is considered to be one of the most important scientific events in biomedicine in 2017. The conference topics includes: personalized and regenerative medicine, pharmacogenetics, molecular diagnostics, stem cell therapy, epigenetics, microbiome, cancer genetics, forensic and anthropological genetics, etc. There is no doubt: the future of medicine will rely on personalized treatments. During the ISABS 2017 Conference we would like to envision the power and advances of personalized medicine that will create significant value for the healthcare system.

(Logo: http://mma.prnewswire.com/media/465687/St_Catherine_Hospital_Logo.jpg )

More than 50 invited speakers from the World's best scientific institutions as well as 500 participants will attend the Conference. Five Nobel Lectures will be given by the Nobel Laureates: prof. Ada Yonath (Weizmann Institute of Science), prof. Robert Huber (Max Planck Institute of Biochemistry), prof. Avram Hershko (Technion), prof. Herald zur Hausen (University of Heidelberg) and prof. Paul Modrich (Duke University).

International Society for Applied Biological Sciences (ISABS) is a member of the Association Academy of the American Academy of Forensic Sciences and one of the most important and influential society in the field of forensic genetics and personalized medicine. ISABS Scientific Committee comprise four Nobel Prize laureates and many of the world's top physicians and scientists.

According to U.S. News & Word Report, Mayo Clinic is the #1 hospital overall, as well as #1 in more specialties than any other hospital in the United States.
St. Catherine Hospital is a European center of excellence, a finalist of the European Business Award and a member of the prestigious group "The Leading Hospitals of The World".

Royal Philips, a leading global company in health technology, is focused on improving people's health and enabling better outcomes with meaningful innovations. Philips is shaping the future of personalized medicine with tools and services that enable patient-specific care with first-time-right decision-making and targeted therapy.

More information on "The Tenth ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine" are available at http://www.isabs.hr .
ISABS 2017 Organizing Committee
info@isabs.hr
Contact: Severina Subotic +385-91-2445-589
Source: International Society for Applied Biological Sciences (ISABS)

Latest Press Release

2017 Cigna 360 degree Well-being Survey - Positive Aspects of Working Overseas Often Overshadowed by Health and Financial concerns

- Globally mobile individuals perceive themselves as worse-off than individuals who reside in their home country and have not taken overseas assignments - Family time and support are major concerns - Many worry about the financial consequence and...

Pan Rajdhevee Group Unveils Pan Acne Formula Three Lotion, the Worlds First Acne Solution Innovation, with the #ShockAcneIn3Days Campaign

Pan Rajdhevee Group, Thailand's leading cosmeceutical brand, pushed forth in continuously developing skincare innovations and introduced "Pan Acne Formula Three Lotion," the ultimate acne solution without relying on any medicine. The solution targets...

ViiV Healthcare Announces Superior Efficacy of Dolutegravir Versus Lopinavir/Ritonavir in Second-line HIV Treatment in Resource-limited Settings

DAWNING study modified to allow patients the opportunity to receive dolutegravir-based regimens ViiV Healthcare, the global specialist HIV company, majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, today announced positive...

Unique concept of MDx, Seegene Random Access System, announced at AACC 2017

Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the "System") at the 69th AACC Annual Clinical Lab Expo in San Diego, CA, from July...

U.S. FDA Determines Celliant(R) Responsive Textile Products Meet Criteria as Medical Devices and General Wellness Products

- Celliant-engineered products clinically proven to promote increased localized blood flow - FDA determination to usher in new era of performance fabrics, responsive textiles Hologenix, LLC, maker of Celliant , the world's most advanced, clinically...

Related Topics